Here are relevant reports on : ophthalmic-drugs-market
-
Cannula Market by Product (Nasal, Arterial, Arthroscopy, Ophthalmic, Cardioplegia, Suction, Femoral, Injector, Infusion, Venous, Microcannula), Material (Plastic, Metal) & End User (Hospitals, Ambulatory Surgical Centers) - Global Forecast to 2020
The cannula market is estimated to grow at a CAGR of 5.6% from 2015 to 2020 to reach $135.5 million by 2020.The report segments the global cannula market by product, by material, by application, by end-users and region. On the basis of material, the market is divided into plastic, metal and silicone. The silicone material is estimated to be the fastest growing segment during the forecast period. On the basis of end users, the cannulas market is divided into hospitals, ambulatory surgical centers, and others (blood banks and home healthcare facilities).
- Published: April 2015
- Price: $ 4950
- TOC Available:
-
North America Human Microbiome Market By Drug & Supplement (Drugs, Probiotics, Prebiotics), Disease (Infectious, Gastrointestinal, Endocrine & Metabolic Diseases), Type (BCT/FMT, LBP), End User (Hospitals, Clinics, Long-term Care) - Forecast to 2031
North America Human Microbiome market, valued at US$0.43 billion in 2024, stood at US$0.78 billion in 2025 and is projected to advance at a resilient CAGR of 32.2% from 2025 to 2031, culminating in a forecasted valuation of US$4.15 billion by the end of the period. New startups in the US and Canada are driving innovation across microbiome therapeutics and diagnostics.
- Published: December 2025
- Price: $ 4950
- TOC Available:
-
Antipsychotic Drugs Market by Therapeutic Class (First Generation, Second Generation, Third Generation), Drug (Aripiprazole, Brexipiprazole, Risperidone), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) - Global Forecast to 2027
The global antipsychotic drugs market is projected to reach USD ~25 billion by 2027 from USD 14 billion in 2022, at a CAGR of 8% between 2022 and 2027.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Skin Cancer Drugs Market by Type (Chemotherapy, Immunotherapy), Disease Indication (Melanoma, Basal and Squamous), Distribution Channel – Global Forecast to 2027
The global skin cancer drugs market is projected to reach USD ~6 billion by 2027 from USD 4 billion in 2022, at a CAGR of 9 % during the forecast period
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Human Microbiome Drugs Market by Type (Live Biotherapeutic Products, Fecal Microbiota-derived Therapeutics), Disease (Gastrointestinal, Infectious), End User (Hospitals, Clinics, Long-term Care) - Global Forecast to 2031
The human microbiome drugs market, valued at US$0.09 billion in 2024, stood at US$0.35 billion in 2025 and is projected to advance at a resilient CAGR of 35.2% from 2025 to 2031, culminating in a forecasted valuation of US$2.13 billion by the end of the period. The human microbiome drugs market is growing, driven by the increasing clinical success of live biotherapeutic products, rising prevalence of chronic and recurrent diseases, and expanding therapeutic applications beyond gastrointestinal disorders into metabolic, immune, and neurological conditions.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
RNA Therapeutics Market by Product (Vaccines, Drugs), Type (mRNA Therapeutics, RNA Interference, Antisense Oligonucleotides), Indication (Infectious Diseases, Rare Genetic Diseases), End User (Hospitals & Clinics) & Region - Global Forecast to 2028
The global RNA therapeutics market, valued at US$32.2 billion in 2022, stood at US$13.7 billion in 2023 and is projected to advance at a resilient CAGR of 5.6% from 2023 to 2028, culminating in a forecasted valuation of US$18.0 billion by the end of the period. Growth in this market is largely driven by factors such as the increasing number of partnerships and collaborations among market players and RNA technology manufacturers, expanding modalities for RNA therapeutics, and the rising number of emergency use authorizations and approvals for COVID-19 booster vaccines.
- Published: September 2023
- Price: $ 4950
- TOC Available:
-
Osteoarthritis Therapeutics Market by Anatomy (Knee, Hand), Drug Type (NSAIDs, Analgesics, Corticosteroids), Route of Administration (Parenteral), Distribution Channel (Hospital Pharmacies), Purchasing Pattern (Prescription Drugs) - Global Forecasts to 2025
The global osteoarthritis therapeutics market growth is primed to transition from USD 7.3 billion in 2020 to USD 11.0 million by 2025, showcasing a strong CAGR of 8.7%.
- Published: December 2020
- Price: $ 4950
- TOC Available:
-
Veterinary Dermatology Market by Route of Administration, Product type (Antibacterial, Antifungal, Antiparasitic Drugs, Monoclonal Antibodies), Condition type (Parasitic Infections, Infectious Diseases, Skin Cancer), Animal type - Global Forecast to 2030
Global veterinary dermatology market valued at $18.59B in 2024, reached $20.11B in 2025, and is projected to grow at a robust 8.5% CAGR, hitting $ 30.31B by 2030. The major factors that are driving the market are expanding companion animal population and pet ownership, growing concerns about infectious zoonotic diseases, rising awareness initiatives by government and animal welfare organizations, and increased adoption of pet insurance and high animal healthcare expenditure.
- Published: March 2025
- Price: $ 4950
- TOC Available:
-
Oligonucleotide Synthesis Market by Product ((Drugs (ASO, siRNA), Synthesized Oligos (Product (Primers, Probes)), Type ((Custom, Predesigned), Reagents, Equipment), Application (Therapeutic (Rare Diseases), Research, Diagnostics) - Global Forecast to 2030
The global oligonucleotide synthesis market, valued at US$8.9 billion in 2024, stood at US$10.5 billion in 2025 and is projected to advance at a resilient CAGR of 18.6% from 2025 to 2030, culminating in a forecasted valuation of US$24.7 billion by the end of the period. The oligonucleotide synthesis market is experiencing significant growth, driven by the increasing applications of synthesized oligonucleotides in therapeutics & diagnostics. This growth is supported by technological advancements and rising investments in life sciences research and synthetic biology.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
3D Printed Drugs Market by Dosage Form (Tablet, Capsule, Nanoparticles), Technology (Inkjet Printing, Zipdose, Direct Write, Stereolithography, Fused Deposition Modeling), Application (Orthopedic, Neurology, Dental) - Global Forecast to 2027
The global 3D Printed Drugs market is projected to reach USD 110 million by 2027 from ~USD 50 million in 2022, at a CAGR of 17% during the forecast period
- Published: February 2026
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
